232 related articles for article (PubMed ID: 31046428)
21. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.
Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H
Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483
[TBL] [Abstract][Full Text] [Related]
22. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.
Marampon F; Megiorni F; Camero S; Crescioli C; McDowell HP; Sferra R; Vetuschi A; Pompili S; Ventura L; De Felice F; Tombolini V; Dominici C; Maggio R; Festuccia C; Gravina GL
Cancer Lett; 2017 Jul; 397():1-11. PubMed ID: 28342984
[TBL] [Abstract][Full Text] [Related]
23. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
24. SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes.
Zeng L; Zheng W; Liu X; Zhou Y; Jin X; Xiao Y; Bai Y; Pan Y; Zhang J; Shao C
Theranostics; 2023; 13(11):3725-3743. PubMed ID: 37441590
[No Abstract] [Full Text] [Related]
25. Overexpressed miR-183 promoted glioblastoma radioresistance via down-regulating LRIG1.
Fan H; Yuan R; Cheng S; Xiong K; Zhu X; Zhang Y
Biomed Pharmacother; 2018 Jan; 97():1554-1563. PubMed ID: 29793318
[TBL] [Abstract][Full Text] [Related]
26. Deregulated microRNAs identified in isolated glioblastoma stem cells: an overview.
Chu PM; Ma HI; Chen LH; Chen MT; Huang PI; Lin SZ; Chiou SH
Cell Transplant; 2013; 22(4):741-53. PubMed ID: 23127968
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies.
Li R; Wang H; Liang Q; Chen L; Ren J
Biomater Sci; 2022 Feb; 10(4):892-908. PubMed ID: 34989724
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Radioresponse and Radiosensitizers in Glioblastoma Organotypic Cultures.
Bayin NS; Ma L; Placantonakis DG; Barcellos-Hoff MH
Methods Mol Biol; 2018; 1741():171-182. PubMed ID: 29392699
[TBL] [Abstract][Full Text] [Related]
29. The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease.
Candido S; Lupo G; Pennisi M; Basile MS; Anfuso CD; Petralia MC; Gattuso G; Vivarelli S; Spandidos DA; Libra M; Falzone L
Oncol Rep; 2019 Sep; 42(3):911-922. PubMed ID: 31322245
[TBL] [Abstract][Full Text] [Related]
30. New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity.
Henry A; Nokin MJ; Leroi N; Lallemand F; Lambert J; Goffart N; Roncarati P; Bianchi E; Peixoto P; Blomme A; Turtoi A; Peulen O; Habraken Y; Scholtes F; Martinive P; Delvenne P; Rogister B; Castronovo V; Bellahcène A
Oncotarget; 2016 Sep; 7(39):63708-63721. PubMed ID: 27563812
[TBL] [Abstract][Full Text] [Related]
31. Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines.
van Nifterik KA; van den Berg J; Stalpers LJ; Lafleur MV; Leenstra S; Slotman BJ; Hulsebos TJ; Sminia P
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1246-53. PubMed ID: 17967314
[TBL] [Abstract][Full Text] [Related]
32. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
33. miR-454-3p exerts tumor-suppressive functions by down-regulation of NFATc2 in glioblastoma.
Zuo J; Yu H; Xie P; Liu W; Wang K; Ni H
Gene; 2019 Aug; 710():233-239. PubMed ID: 31181312
[TBL] [Abstract][Full Text] [Related]
34. Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma.
Degorre C; Tofilon P; Camphausen K; Mathen P
Radiat Oncol; 2021 Sep; 16(1):191. PubMed ID: 34583727
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
Chang JE; Khuntia D; Robins HI; Mehta MP
Clin Adv Hematol Oncol; 2007 Nov; 5(11):894-902, 907-15. PubMed ID: 18185489
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
[TBL] [Abstract][Full Text] [Related]
37. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y
EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs as Multifaceted Players in Glioblastoma Multiforme.
Mercatelli N; Galardi S; Ciafrè SA
Int Rev Cell Mol Biol; 2017; 333():269-323. PubMed ID: 28729027
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-135b exerts oncogenic activity in glioblastoma via the inhibition of glycerol kinase 5 expression.
Yu Y; Zhang JH; Zhang BZ
Mol Med Rep; 2015 Aug; 12(2):2721-6. PubMed ID: 25936394
[TBL] [Abstract][Full Text] [Related]
40. Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors.
Sharma V; Purkait S; Takkar S; Malgulwar PB; Kumar A; Pathak P; Suri V; Sharma MC; Suri A; Kale SS; Kulshreshtha R; Sarkar C
Brain Tumor Pathol; 2016 Apr; 33(2):117-28. PubMed ID: 26746204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
